The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Understand the balance between pro-hemorrhagic and pro-thrombotic tendencies in patients with cirrhosis at different stages
Understand the limitations of standard coagulation tests (INR, platelet count, fibrinogen) in predicting risk of post-procedural bleeding in patients with cirrhosis
Gain knowledge on the risk and potential benefits of blood product transfusion prior to invasive procedures in patients with cirrhosis
Debater(s):
Dr. Andres
Cardenas,
MD, MMSC, PHD, AGAF, FAASLD,
Assosciate Professor of Medicine,
University of Barcelona